Eric Tse
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Oncology top 1%
- Viral-associated cancers and disorders
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 45
- Viral-associated cancers and disorders 26
- Peptidase Inhibition and Analysis 8
-
- Lymphoma Diagnosis and Treatment 39
- Co-authors
- Yok‐Lam Kwong (72 shared papers)Anskar Y.H. Leung (18 shared papers)Terence H. Rabbitts (6 shared papers)Seok Jin Kim (3 shared papers)Chor Sang Chim (13 shared papers)Joanne Wing Yan Chiu (1 shared paper)Thomas Yau (1 shared paper)Gerry Gin Wai Kwok (1 shared paper)
- Journals
- Blood (11 papers)Annals of Hematology (9 papers)Bone Marrow Transplantation (5 papers)American Journal of Hematology (4 papers)Journal of Hematology & Oncology (4 papers)
- Partner nations
- ChinaHong KongUnited Kingdom
In The Last Decade
Eric Tse
109 papers receiving 4.9k citations
Eric Tse's Hit Papers
Peers
Comparison fields: 5 of 120
- Pathology and Forensic Medicine 1.8k
- Oncology 1.8k
- Immunology 1.3k
- Genetics 353
- Hematology 363
Countries citing papers authored by Eric Tse
This map shows the geographic impact of Eric Tse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Tse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Tse more than expected).
Fields of papers citing papers by Eric Tse
This network shows the impact of papers produced by Eric Tse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Tse. The network helps show where Eric Tse may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Tse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase Hit paper breakdown → | 2017 | 368 |
| 2 | 2016 | 351 | |
| 3 | 2012 | 301 | |
| 4 | 2017 | 217 | |
| 5 | 2013 | 210 | |
| 6 | 2004 | 204 | |
| 7 | 2005 | 191 | |
| 8 | 1999 | 158 | |
| 9 | 2010 | 146 | |
| 10 | 2012 | 124 | |
| 11 | 2006 | 111 | |
| 12 | 2006 | 108 | |
| 13 | 2017 | 108 | |
| 14 | 2015 | 98 | |
| 15 | 2013 | 93 | |
| 16 | 2004 | 90 | |
| 17 | 2005 | 86 | |
| 18 | 2002 | 82 | |
| 19 | 2004 | 72 | |
| 20 | 2010 | 68 |
About Eric Tse
Eric Tse is a scholar working on Oncology, Pathology and Forensic Medicine, Molecular Biology, Immunology and Hematology, having authored 113 papers that have together received 4.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (39 papers), Viral-associated cancers and disorders (26 papers), Chronic Lymphocytic Leukemia Research (16 papers), Immune Cell Function and Interaction (14 papers), Signaling Pathways in Disease (13 papers), Retinoids in leukemia and cellular processes (8 papers), Peptidase Inhibition and Analysis (8 papers) and Acute Myeloid Leukemia Research (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.8k citations), Oncology (1.8k citations), Immunology (1.3k citations), Genetics (353 citations) and Hematology (363 citations). Eric Tse has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Yok‐Lam Kwong, Anskar Y.H. Leung, Terence H. Rabbitts, Seok Jin Kim, Chor Sang Chim, Joanne Wing Yan Chiu, Thomas Yau, Gerry Gin Wai Kwok, Chi-Wai Cheng and Roberta Pang. Their work appears in journals such as Blood, Annals of Hematology, Bone Marrow Transplantation, American Journal of Hematology and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.